Cargando…
VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.
VLA2 is thought to be involved in the metastatic process in malignant tumours, in particular in carcinomatous cell adhesion to vessel basement membrane. VLA2 expression was immunohistochemically investigated in 204 breast carcinomas. Frozen tissue sections were probed with monoclonal anti-VLA2 using...
Autores principales: | Charpin, C., Garcia, S., Bergeret, D., Andrac, L., Horschowski, N., Choux, R., Lavaut, M. N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150386/ https://www.ncbi.nlm.nih.gov/pubmed/9649145 |
Ejemplares similares
-
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
por: Charpin, C., et al.
Publicado: (1997) -
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.
por: Charpin, C., et al.
Publicado: (1997) -
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
por: Charpin, C, et al.
Publicado: (2009) -
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007) -
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905)
por: Dales, J P, et al.
Publicado: (2004)